Results 81 to 90 of about 131,902 (175)

Posterior Reversible Encephalopathy Syndrome Associated With Severe Proton Pump Inhibitor-Induced Hypomagnesemia: A Rare Case. [PDF]

Cureus
Ciampa C, Antenora A, Salzano C, Apuzzi V, Bassi V.   +4 more
europepmc   +1 more source

Posterior Reversible Encephalopathy Syndrome (PRES) Associated With Eclampsia in a Pregnant Adolescent: A Case Report. [PDF]

Cureus
Gómez KA, Rojas Cuadros YE, Sierra Rosales G.   +2 more
europepmc   +1 more source

Central-variant posterior reversible encephalopathy syndrome mimicking tumor progression in a glioblastoma patient on bevacizumab: illustrative case. [PDF]

J Neurosurg Case Lessons
Kobayashi Y, Kawauchi Y, Sato Y, Yoshiyama T, Natori I, Tanioka D, Morofuji Y.   +6 more
europepmc   +1 more source

HBV integration into KMT2B increases malignant phenotype of hepatocellular carcinoma by epigenetic reprogramming. [PDF]

Cell Insight
Fu C, Wu T, Meng R, Liu W, Li Z, Chen X, Zhang Q, Ji X, Cao G.   +8 more
europepmc   +1 more source

Posterior Reversible Encephalopathy Syndrome (PRES) in an Anuric Patient With a WT1 Mutation and Chronic Renal Graft Failure: A Case Report. [PDF]

Cureus
Massinon C, Boer W, Honoré PM.
europepmc   +1 more source

Hemorrhagic posterior reversible encephalopathy syndrome with pontine infarction in early-onset eclampsia: An atypical MRI spectrum. [PDF]

Radiol Case Rep
Nalla S, Patil PS, Swathi P.
europepmc   +1 more source

The onset of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) with the use of decongestant agents: a European pharmacovigilance analysis. [PDF]

Pharmacol Rep
Anatriello A, Cantone A, Pentella C, Vastarella MG, Mascolo A, Capuano A, Rafaniello C.   +6 more
europepmc   +1 more source

Lenvatinib-Associated Posterior Reversible Encephalopathy Syndrome in a Patient With Metastatic Clear Cell Renal Cell Carcinoma: A Case Report. [PDF]

Cureus
Luginaah NA, Climans S, Akingbade A.
europepmc   +1 more source

Polycomb Group Proteins in <i>Drosophila melanogaster</i>. [PDF]

Biology (Basel)
Gao F, Li Z, Yu X, Chen S, Ye C.
europepmc   +1 more source

Posterior reversible encephalopathy syndrome across 22 VEGF-pathway inhibitors in the FDA adverse event reporting system: reporting patterns and reporting-interval characteristics. [PDF]

Front Pharmacol
Li J, Cheng Y, Yang Y.
europepmc   +1 more source